Quantitative Investment Management, LLC - REPLIGEN CORP ownership

REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 438 filers reported holding REPLIGEN CORP in Q4 2022. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.

Quarter-by-quarter ownership
Quantitative Investment Management, LLC ownership history of REPLIGEN CORP
ValueSharesWeighting
Q3 2022$706,000
+195.4%
3,775
+206.9%
0.12%
+485.0%
Q1 2021$239,000
-84.7%
1,230
-90.3%
0.02%
-87.6%
Q2 2020$1,566,000
+114.2%
12,673
+32.8%
0.16%
+312.8%
Q3 2019$731,000
+117.6%
9,542
+67.4%
0.04%
+105.3%
Q1 2019$336,000
+21.3%
5,700
+14.0%
0.02%
+90.0%
Q3 2018$277,000
-84.4%
5,000
-89.2%
0.01%
-50.0%
Q3 2017$1,781,000
-49.9%
46,500
-45.8%
0.02%
-62.3%
Q2 2017$3,555,000
+1165.1%
85,800
+972.5%
0.05%
+1225.0%
Q1 2017$281,000
+22.2%
8,000
-7.0%
0.00%
-63.6%
Q1 2016$230,0008,6000.01%
Other shareholders
REPLIGEN CORP shareholders Q4 2022
NameSharesValueWeighting ↓
12 West Capital Management LP 1,021,641$295,244,00013.47%
Ally Bridge Group (NY) LLC 70,000$20,229,0005.95%
Miura Global Management 85,000$24,564,0003.81%
Conestoga Capital Advisors, LLC 871,390$251,823,0003.48%
Ranger Investment Management 187,723$54,250,0002.90%
AWM Investment Company, Inc. 100,000$28,899,0002.84%
Brown Capital Management 1,017,477$294,041,0002.41%
Stephens Investment Management Group LLC 558,287$161,339,0002.19%
Yorktown Management & Research Co Inc 10,050$2,904,0002.18%
SV Health Investors, LLC 14,541$4,203,0002.06%
View complete list of REPLIGEN CORP shareholders